STOCK TITAN

111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

111, Inc. (NASDAQ: YI), a leading tech-enabled healthcare platform in China, will join a fireside chat with Robert Sassoon from Water Tower Research on October 30, 2024 at 12:00 p.m. ET. Dr. Gang Yu, Co-Founder and Executive Chairman, will discuss the company's logistics network, including its fulfillment centers, operating models, and technological innovations. He will also cover the expansion plans. To register for this listen-only event, visit the provided link. A replay will be available under 'Events' on the company's investor relations website.

111, Inc. (NASDAQ: YI), una piattaforma sanitaria abilitata dalla tecnologia leader in Cina, parteciperà a un fireside chat con Robert Sassoon di Water Tower Research il 30 ottobre 2024 alle 12:00 ET. Il Dr. Gang Yu, Co-Fondatore e Presidente Esecutivo, discuterà della rete logistica dell'azienda, comprese le sue strutture di evasione degli ordini, i modelli operativi e le innovazioni tecnologiche. Parlerà anche dei piani di espansione. Per registrarsi a questo evento accessibile solo in ascolto, visitare il link fornito. Una registrazione sarà disponibile nella sezione 'Eventi' sul sito web delle relazioni con gli investitori dell'azienda.

111, Inc. (NASDAQ: YI), una plataforma de atención médica habilitada por tecnología líder en China, participará en un fireside chat con Robert Sassoon de Water Tower Research el 30 de octubre de 2024 a las 12:00 p.m. ET. El Dr. Gang Yu, Co-Fundador y Presidente Ejecutivo, discutirá sobre la red logística de la compañía, que incluye sus centros de cumplimiento, modelos operativos e innovaciones tecnológicas. También abordará los planes de expansión. Para registrarse en este evento de solo escucha, visite el enlace proporcionado. Se podrá acceder a una repetición en la sección 'Eventos' del sitio web de relaciones con inversores de la empresa.

111, Inc. (NASDAQ: YI), 중국에서 기술 기반의 선도 건강 관리 플랫폼, 가 2024년 10월 30일 오후 12:00 ET에 Water Tower Research의 Robert Sassoon과 파이어사이드 채팅에 참여할 것입니다. 공동 설립자이자 임시 의장인 강 유 박사는 회사의 물류 네트워크, 이행 센터, 운영 모델 및 기술 혁신에 대해 논의합니다. 그는 또한 확장 계획에 대해 언급할 것입니다. 이 청취 전용 이벤트에 등록하려면 제공된 링크를 방문하십시오. 회사의 투자자 관계 웹사이트 '이벤트' 섹션에서 재생을 사용할 수 있습니다.

111, Inc. (NASDAQ: YI), une plateforme de santé activée par la technologie leader en Chine, participera à un fireside chat avec Robert Sassoon de Water Tower Research le 30 octobre 2024 à 12h00 ET. Le Dr Gang Yu, co-fondateur et président exécutif, discutera du réseau logistique de l'entreprise, y compris des centres de distribution, des modèles opérationnels et des innovations technologiques. Il couvrira également les plans d'expansion. Pour vous inscrire à cet événement d'écoute uniquement, visitez le lien fourni. Un enregistrement sera disponible dans la section 'Événements' sur le site Web des relations avec les investisseurs de l'entreprise.

111, Inc. (NASDAQ: YI), eine führende technologiegestützte Gesundheitsplattform in China, wird am 30. Oktober 2024 um 12:00 Uhr ET an einem Fireside Chat mit Robert Sassoon von Water Tower Research teilnehmen. Dr. Gang Yu, Mitgründer und Vorstandsvorsitzender, wird über das Logistiknetzwerk des Unternehmens sprechen, einschließlich der Erfüllungszentren, Betriebsmodelle und technologischen Innovationen. Auch die Expansionspläne werden behandelt. Um sich für diese nur anhörbare Veranstaltung anzumelden, besuchen Sie den bereitgestellten Link. Eine Wiederholung wird im Abschnitt 'Veranstaltungen' auf der Investor Relations-Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, October 30, 2024 at 12:00 p.m. ET.

Dr. Gang Yu, Co-Founder and Executive Chairman of 111, will discuss the Company's logistics network, including an overview of its fulfillment centers, operating models, and technological innovations enhancing procurement and last-mile delivery in addition to the network's plans for expansion.

To register for this listen-only event, please visit:

Fireside Chat Registration Link

The replay of the fireside chat will be available under "Events" in the 111's investor relations website at http://ir.111.com.cn/.

Forward-Looking Statements

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as 111's strategic and operational plans, contain forward-looking statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

Cision View original content:https://www.prnewswire.com/news-releases/111-inc-to-participate-in-fireside-chat-with-water-tower-research-on-october-30-2024-302282920.html

SOURCE 111, Inc.

FAQ

When will 111, Inc. participate in the fireside chat with Water Tower Research?

111, Inc. will participate in the fireside chat on October 30, 2024, at 12:00 p.m. ET.

What topics will be discussed by 111, Inc. during the fireside chat?

Dr. Gang Yu will discuss 111, Inc.'s logistics network, including fulfillment centers, operating models, technological innovations, and expansion plans.

How can I register for the 111, Inc. fireside chat event on October 30, 2024?

You can register for the listen-only event by visiting the provided registration link.

Where can I find the replay of 111, Inc.'s fireside chat with Water Tower Research?

The replay will be available under 'Events' on 111, Inc.'s investor relations website at http://ir.111.com.cn/.

111, Inc. American Depositary Shares

NASDAQ:YI

YI Rankings

YI Latest News

YI Stock Data

52.26M
33.71M
16.16%
23.9%
0.04%
Medical Distribution
Healthcare
Link
United States of America
Shanghai